Research
Hormonal
GLP-1 receptor agonists produce significant weight loss.
Practitioners can consider GLP-1 receptor agonists as a viable option for weight loss in patients with obesity.
StrongSupportsmedium confidence
Over the last decade, glucagon-like peptide-1 (GLP-1) receptor agonists, a novel group of medications for the treatment of type 2 diabetes, were found to produce significant weight loss.
Why this rating
The claim is based on research findings mentioned in the abstract.
Source
Pharmacotherapy of Weight‐loss and Obesity with a Focus on GLP 1‐Receptor Agonists
Merle Myerson et al. · The Journal of Clinical Pharmacology · 2024
reviewCited 17×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →